Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards

MLA

Vita Brisnik, et al. “Potential Deprescribing Indications for Antidepressants between 2012 and 2019: Repeated Cross-Sectional Analysis in Two Scottish Health Boards.” BMC Medicine, vol. 22, no. 1, Sept. 2024, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s12916-024-03584-9.

APA

Vita Brisnik, Marietta Rottenkolber, Jochen Vukas, Miriam Schechner, Karoline Lukaschek, Caroline Jung-Sievers, Jochen Gensichen, Ulrich Thiem, Michael Drey, Nils Krüger, Alpana Mair, Bruce Guthrie, Sebastian Fischer, Tobias Dreischulte, & for the POKAL Study Group. (2024). Potential deprescribing indications for antidepressants between 2012 and 2019: repeated cross-sectional analysis in two Scottish health boards. BMC Medicine, 22(1), 1–14. https://doi.org/10.1186/s12916-024-03584-9

Chicago

Vita Brisnik, Marietta Rottenkolber, Jochen Vukas, Miriam Schechner, Karoline Lukaschek, Caroline Jung-Sievers, Jochen Gensichen, et al. 2024. “Potential Deprescribing Indications for Antidepressants between 2012 and 2019: Repeated Cross-Sectional Analysis in Two Scottish Health Boards.” BMC Medicine 22 (1): 1–14. doi:10.1186/s12916-024-03584-9.